Why rates of radiation pneumonitis are high over time with raising use of immunotherapy – MSK Radiation Oncology

Memorial Sloan Kettering Radiation Oncology shared on X/Twitter:

“Dr. Narek Shaverdian presents at our ‘Work in Progress’ thoracic radiation oncology meeting at Memorial Sloan Kettering Cancer Center on why rates of radiation pneumonitis are high over time with raising use of immunotherapy and why it is an important target for intervention to improve lung cancer outcomes.”

Source: Memorial Sloan Kettering Radiation Oncology/X